logo
logo

Culture Biosciences Raises $80M Series B To Tackle Demand For Large-Scale Biomanufacturing

Oct 14, 2021•almost 4 years ago

Amount Raised

$80 Million

Round Type

series b

San Francisco

Description

Culture Biosciences, a company enabling biotech firms to develop and scale manufacturing processes in the cloud, announced a Series B financing of $80 million led by Northpond Ventures. Synthesis Capital also participated in the round. Existing investors Cultivian Sandbox Ventures, The Production Board, Craft Ventures, E14 Fund, Box Group, Verily Life Sciences, and Section 32 also contributed. Andrew Lee, Ph.D., of Northpond Ventures will join Culture’s Board of Directors.

Company Information

Company

Culture Biosciences

Location

San Francisco, California, United States

About

Culture Biosciences is a technology company in South San Francisco, CA, offering biotechnology companies an easier, faster, and cheaper way to do biomanufacturing R&D. By leveraging Culture’s cloud bioreactor platform, bioprocess scientists can spend more time designing and analyzing experiments. Culture’s cloud bioreactors offer full control of experimental design and allow real-time monitoring and process changes. Beyond generating data more quickly, Culture’s platform provides advanced data visualization and analytics tools to generate new insights into bioprocesses. Learn more here about career opportunities at Culture and our team’s passion for solving the world’s biomanufacturing capacity problem.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech